InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that senior management including Moshe Mizrahy, Chairman and Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the 7 th Annual Needham Virtual Med Tech & Diagnostics Conference.
| YOKNEAM, Israel, Aug. 8, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that senior management including Moshe Mizrahy, Chairman and Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics one-on-one Conference on Tuesday, Aug. 16, 2022. 
The company will hold one-on-one investor meetings that same day. To schedule a meeting, please contact your Needham representative. For more information about the event, visit InMode’s investor relations site here. About InMode InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Investor Relations Contact: Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
SOURCE InMode Ltd. | ||
Company Codes: NASDAQ-NMS:INMD |
View original content:
